Summary

Nathan Shock, a co-director of the University of Washington's Nathan Shock Center of Excellence in Basic Biology of Aging, leads the Dog Aging Project for testing rapamycin in companion dogs. The individual, who was also named a Rising Star for Aging Research in 2011, served as a Fellow of the Gerontological Society of America and was appointed a Board of Director of the American Aging Association in 2012. His extensive career in cellular aging research highlights his commitment to advancing human and animal models for geriatric medicine.

Title

Healthspan Capital

Description

Healthspan Capital is an early-stage longevity venture capital firm that invests in biotechnology startups developing therapies to slow or reverse aging.

Keywords

aging, university, longevity, research, biotech, biology, director, institute, fellow, venture, advisor, contact, biotechnology, michael, professor, capital, startups

NS Lookup

A 198.202.211.1

Dates

Created 2026-04-13

Updated 2026-04-13

Summarized 2026-04-26